Marc Destito

Marc Destito, based in Geneva, Switzerland, joined QIAGEN as Vice President and Head of Global Health in July 2021 focusing on infectious diseases, tuberculosis (TB) and women’s health. In this role he leads QIAGEN’s Global Public Health Task Force, working to expand access and affordability to QIAGEN’s diagnostic solutions for low-resource settings and vulnerable populations. Previously, he helped lead the global TB program for Otsuka Pharmaceutical, focused on drug development for multidrug-resistant TB (MDR-TB). He holds an advanced degree in Global Health Policy from the London School of Hygiene and Tropical Medicine and in International Politics from Georgetown University’s Walsh School of Foreign Service.

retour haut de page